Science Explorer Back to mapMap
Discussion
Researcher · Biotech Park · India

Prabuddha Kumar Kundu

Prabuddha Kumar Kundu publishes mostly in Molecular Biology, Infectious Diseases and Oncology, on topics such as 3D Printing in Biomedical Research, SARS-CoV-2 and COVID-19 Research and Cancer Cells and Metastasis.

ORCID 0000-0002-9447-2812 OpenAlex
World rank
#5,236,062
of 7,710,434 ranked researchers
Rank in India
#147,932
of 280,097
Works
19
Citations
246
Citations per work
12.9
h-index
6
i10-index 3Top 94% in Molecular Biology
Prabuddha Kumar Kundu

What does Prabuddha Kumar Kundu research?

Prabuddha Kumar Kundu's work is mostly in Medicine (31%), Biochemistry, Genetics and Molecular Biology (24%), Engineering (8%).

Everything else: 7 works · 37.4% of their workHealth Sciences: 6 works · 31.3% of their workMedicine: 6 works · 31.3% of their workInfectious Diseases: 3 works · 13.7% of their workOncology: 2 works · 9.8% of their workCardiology and Cardiovascular Medicine: 1 works · 3.9% of their workPhysiology: 1 works · 3.9% of their workLife Sciences: 4 works · 23.5% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 23.5% of their workMolecular Biology: 4 works · 23.5% of their workPhysical Sciences: 1 works · 7.8% of their workEngineering: 1 works · 7.8% of their workBiomedical Engineering: 1 works · 7.8% of their workTHEIR WORKPrabuddha KumarKundu19works
Life Sciences24%Physical Sciences8%Health Sciences31%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else737.4%
    1. Medicine631.3%
    1. Biochemistry, Genetics and Molecular Biology423.5%
    1. Engineering17.8%
  1. 1Molecular Biology24% of their works
  2. 2Infectious Diseases14% of their works
  3. 3Oncology10% of their works
  4. 4Biomedical Engineering8% of their works
  5. 5Physiology4% of their works
  6. 6Cardiology and Cardiovascular Medicine4% of their works

Research topics

Which keywords describe Prabuddha Kumar Kundu's research?

The keywords of their largest research topics: Tissue Engineering, Coronavirus, Vaccine, Bioprinting, Cancer Stem Cells, Microfluidic Devices, SARS-CoV-2 and spike protein.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Tissue Engineering62 topics
  2. Coronavirus52 topics
  3. Vaccine52 topics
  4. Bioprinting41 topic
  5. Cancer Stem Cells41 topic
  6. Microfluidic Devices41 topic
  7. SARS-CoV-241 topic
  8. Tumor Metastasis41 topic
  9. spike protein41 topic
  10. Metagenomics32 topics
  11. Cell Mechanics21 topic
  12. Ecology21 topic
  13. Epitope Prediction21 topic
  14. Extracellular Matrix21 topic
  15. Peptide-MHC Binding21 topic
  16. Virus21 topic
  17. Circovirus11 topic
  18. Electromagnetic Fields11 topic
  19. Magnetoreception11 topic
  20. Porcine Reproductive and Respiratory Syndrome Virus11 topic

Where does Prabuddha Kumar Kundu work?

Prabuddha Kumar Kundu's main affiliation in the publication record is Biotech Park, India.

How many publications and citations does Prabuddha Kumar Kundu have?

OpenAlex counts 19 works and 246 citations for Prabuddha Kumar Kundu, an h-index of 6, ranking #5,236,062 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Prabuddha Kumar Kundu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.